Merck Halts Study on Vitamin B-Based Cholesterol Drug
foxnews.com     May 22, 2008            

Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to allow sales of the drug. The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

International Struggle to Develop HIV/AIDS Vaccine Continues

usmission.gov     8 hrs ago   36 related          

By Cheryl Pellerin Staff Writer Washington – The 20-year effort to develop a vaccine that protects against the AIDS-causing human immunodeficiency virus (HIV) meets more challenges as clinical trials are discontinued and the...                

comments

                   

Docs Debate Cancer Risk of Heart Drug

go.com     1 hr ago   11 related          

Cardiologists Debate Evidence of Vytorin's "Disturbing" Cancer Link By STEVE STERNBERG USA TODAY A study that unexpectedly linked the heart drug Vytorin to excess cancer deaths has provoked controversy among heart specialists...                

comments

                   

Statins 'lower risk of death'

news24.com     11 hrs ago   2 related          

Will Dunham Washington - Cholesterol-fighting statin drugs, already known to help ward off heart attacks and strokes, may help people who have received a kidney transplant live longer, researchers said on Wednesday. The study,...                

comments

The Heart of an Artichoke

care2.com     14 hrs ago          

Artichokes are a good source of dietary fiber and nutrients such as magnesium, calcium, niacin, potassium and vitamin C. Dietary fiber is essential for gastrointestinal health, and useful for weight management, maintaining...                

comments